Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

Brendan Hannah Net Worth & Insider Trades

Brendan Hannah - Chief Business Officer and COO, Quince Therapeutics, Inc

As of October 26, 2023

What is Brendan Hannah's Net Worth?

The current estimated net worth of Quince Therapeutics, Inc's Chief Business Officer and COO, Brendan Hannah, is estimated to be about $47.37K . Brendan Hannah owns about 201,555 units of Quince Therapeutics, Inc common stock. In the last 9 months at Quince Therapeutics, Inc, Brendan Hannah has sold an estimated value of $0 worth.

What is Brendan Hannah's Past Insider Trading?

Brendan Hannah's largest purchase order was 71,762 units , worth over $87.55K on August 9, 2023. In total, Brendan Hannah has made about 3 transactions over 9 months of their time at Quince Therapeutics, Inc. Brendan Hannah usually trades in October, August and February, with the busiest year in 2023.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Brendan Hannah

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Brendan Hannah's' Mailing Address?

  • Mailing address is 269 East Grand Ave South San Francisco CA 94080 CA

What are Quince Therapeutics, Inc's Past Insider Trades?

Quince Therapeutics, Inc's most recent insider trade came on December 1, 2023 by David Lamond who bought 43,134 units worth $40.55K . In the last 10 months, insiders at Quince Therapeutics, Inc have sold an estimated value of $5.51K and bought an estimated value of $781.65K worth of shares. Insider trading is most common in August, with the busiest year in 2023. The most active traders at the company are David Lamond, Director,  Ted Monohon, Chief Accounting Officer & VP,  and Brendan Hannah, Chief Business Officer and COO .

Quince Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...